Accepted for/Published in: JMIR Research Protocols
Date Submitted: Sep 14, 2023
Date Accepted: Dec 29, 2023
Study Protocol for A Mobile Application to Address Cannabis Use Disorder Among Black Adults
ABSTRACT
Background:
African American/Black (hereafter referred to as Black) adults who use cannabis use more frequently and are more likely to meet criteria for Cannabis Use Disorder (CUD) than both White and Hispanic/Latin individuals. Black adults may be more apt to use cannabis to cope with distress, which constitutes a false safety behavior (FSB; a behavior designed to reduce psychological distress in the short-term). Though FSB engagement can perpetuate the cycle of high rates of CUD among Black individuals, limited work has applied a FSB elimination treatment approach to Black adults with CUD, and no previous work has evaluated FSB reduction/elimination in the context of a culturally tailored and highly accessible treatment developed for Black individuals.
Objective:
The current study aims to develop and pilot test a culturally tailored adaptive intervention that integrated FSB reduction/elimination skills for cannabis reduction/cessation among Black adults with probable CUD (CT-MICART).
Methods:
Black adults with probable CUD (N = 50) will complete an online screener, enrollment call, baseline assessment, 3 daily ecological momentary assessments (EMAs) for 6 weeks, and a follow-up self-report assessment and qualitative interview The current study will provide a unique opportunity to provide healthcare providers and researchers a chance to further refine and provide low-cost and easily accessible treatment for a historically underrepresented and underserved population.at 6-weeks post-randomization. Participants will be randomized into one of two conditions post-baseline: 1) CT-MICART+EMAs for 6 weeks or 2) EMAs only for 6 weeks.
Results:
The current study is open for enrollment and currently recruiting research participants and results have not yet been analyzed.
Conclusions:
The current study will provide a unique opportunity to provide healthcare providers and researchers a chance to further refine and provide low-cost and easily accessible treatment for a historically underrepresented and underserved population.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.